Literature DB >> 21874611

Transplacental digoxin therapy for fetal atrial flutter with hydrops fetalis.

Kai-Yu Zhou1, Yi-Min Hua, Qi Zhu.   

Abstract

BACKGROUND: Without timely treatment, fetal atrial flutter (AF) could result in congestive heart failure, hydrops fetalis and even fetal demise.
METHODS: Prenatal echocardiography was used to confirm AF and assess fetal cardiac function with cardiovascular profile score. Transplacental digoxin therapy was adopted, and the patient was followed up for 10 months.
RESULTS: The healthy male baby was delivered with normal postnatal electrocardiogram and echocardiogram. Neither arrhythmia nor neurodevelopmental impairment was found during the follow-up.
CONCLUSION: Timely transplacental digoxin therapy can successfully treat fetal AF and allow the fetus to recover from AF associated fetal heart failure and hydrops fetalis prior to delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874611     DOI: 10.1007/s12519-011-0306-4

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  8 in total

Review 1.  Drugs in pregnancy. Pharmacokinetics in pregnancy.

Authors:  M Dawes; P J Chowienczyk
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2001-12       Impact factor: 5.237

2.  A cardiovascular profile score in the surveillance of fetal hydrops.

Authors:  Cornelia Hofstaetter; Manfred Hansmann; Sturla H Eik-Nes; James C Huhta; Stephen L Luther
Journal:  J Matern Fetal Neonatal Med       Date:  2006-07

Review 3.  Outcome of fetal cardiac defects.

Authors:  Bettina F Cuneo
Journal:  Curr Opin Pediatr       Date:  2006-10       Impact factor: 2.856

Review 4.  Fetal congestive heart failure.

Authors:  James C Huhta
Journal:  Semin Fetal Neonatal Med       Date:  2005-09-30       Impact factor: 3.926

5.  Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia.

Authors:  M Krapp; T Kohl; J M Simpson; G K Sharland; A Katalinic; U Gembruch
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

6.  Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score.

Authors:  Dhaval Patel; Bettina Cuneo; Regina Viesca; Juha Rassanan; Jenny Leshko; James Huhta
Journal:  J Matern Fetal Neonatal Med       Date:  2008-07

7.  Long-term neurodevelopmental outcome after fetal arrhythmia.

Authors:  Enrico Lopriore; Muhammed I Aziz; Helene T Nagel; Nico A Blom; Lieke Rozendaal; Humphrey H H Kanhai; Frank P H A Vandenbussche
Journal:  Am J Obstet Gynecol       Date:  2009-04-03       Impact factor: 8.661

Review 8.  Cardiac arrhythmias in the human fetus.

Authors:  C S Kleinman; R A Nehgme
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

  8 in total
  1 in total

1.  The study of fetal rat model of intra-amniotic isoproterenol injection induced heart dysfunction and phenotypic switch of contractile proteins.

Authors:  Yifei Li; Jie Fang; Yimin Hua; Chuan Wang; Dezhi Mu; Kaiyu Zhou
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.